V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220009553 | 220003898 | 1.6 | 68 | Curative (C) | 2018-12-01 | 2018-12-01 | CYCLOPHOSPHAMIDE + FLUDARABINE | 02 | N | 220020151 | FLUDARABINE + MELPHALAN |
| 220009554 | 220003899 | null | 87.3 | null | null | 2015-08-02 | Dacarbazine | null | null | 220020309 | LENALIDOMIDE |
| 220009555 | 220003900 | 1.53 | null | null | 2017-09-10 | 2017-09-10 | Triple / Double Intrathecal Therapy | 2 | N | 220020342 | CYTARABINE + FLUDARABINE |
| 220009556 | 220003901 | 1.63 | 75.5 | Palliative (P) | 2016-06-18 | 2016-06-18 | Alemtuzumab cond (RI ALLO CAMP100) | Y | N | 220020350 | FCIST |
| 220009557 | 220012087 | 1.57 | 74 | Curative (C) | 2013-12-23 | 2013-12-23 | IDARUBICIN + MITOXANTRONE + Tretinoin | N | N | 220020384 | FLA |
| 220009558 | 220012087 | 1.66 | null | Curative (C) | 2017-06-13 | 2017-06-18 | Cyclophosphamide+Fludara+TBI Allo | Y | N | 220020384 | ARSENIC TRIOXIDE + TRETINOIN |
| 220009559 | 220012087 | 1.77 | null | Curative (C) | null | 2018-02-20 | CAPECITABINE + MITOMYCIN + RT | N | Y | 220020384 | ALEMTUZUMAB + CYCLO + FLUDARABINE |
| 220009560 | 220003902 | 1.75 | 78 | Curative (C) | 2014-12-29 | 2014-12-29 | ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE | 02 | N | 220020531 | CYCLOPHOSPHAMIDE + FLUDARABINE + THIOTEPA |
| 220009561 | 220012088 | 1.8 | 12.8 | Curative (C) | 2016-09-10 | 2016-09-10 | Fludarabine + Melphalan RIC Allo | 2 | N | 220020546 | BUSULFAN + FLUDARABINE + METHOTREXATE |
| 220009562 | 220012088 | 1.95 | null | null | 2016-02-13 | 2016-02-19 | LENALIDOMIDE | 99 | N | 220020546 | FCIST |
| 220009563 | 220012088 | 1.67 | 48 | Adjuvant (A) | 2014-10-12 | 2014-10-31 | Carboplatin + Docetaxel | 02 | null | 220020546 | CARBOPLATIN + RT |
| 220009564 | 220012088 | 1.73 | 87 | Palliative (P) | 2013-06-13 | 2013-06-13 | Cisplatin + Docetaxel +Fluorouracil | 2 | null | 220020546 | CHOP R |
| 220009565 | 220003903 | 1.69 | 46.7 | Curative (C) | 2014-03-13 | 2014-03-13 | CARBOPLATIN + EPIRUBICIN | N | Y | 220020925 | BEP |
| 220009566 | 220003903 | 1.58 | null | Curative (C) | 2016-01-19 | 2016-02-02 | Capecitabine | N | N | 220020925 | FLUDARABINE + MELPHALAN |
| 220009567 | 220003903 | 1.65 | 42.3 | Palliative (P) | 2018-07-23 | 2018-07-23 | CYCLOPHOSPHAMIDE + FLUDARABINE | N | N | 220020925 | IPILIMUMAB |
| 220009568 | 220003904 | 1.81 | 0 | Curative (C) | 2015-10-28 | 2015-10-28 | Enzalutamide | 02 | N | 220020946 | TRASTUZUMAB |
| 220009569 | 220003905 | 0 | 0 | Palliative (P) | 2013-04-27 | 2013-05-06 | GEMTUZUMAB OZOGAMICIN | 02 | null | 220020972 | CISPLATIN + PEMETREXED |
| 220009570 | 220003906 | null | null | Curative (C) | 2015-02-04 | 2015-02-04 | Cisplatin + Pemetrexed | N | N | 220020987 | FLUDARABINE + MELPHALAN |
| 220009571 | 220012090 | null | null | null | 2018-09-07 | 2018-09-07 | Arsenic trioxide | N | N | 220021062 | ECF |
| 220009572 | 220003907 | 1.71 | null | Curative (C) | 2014-12-20 | 2014-12-20 | Pazopanib | N | N | 220021070 | IVAC |
| 220009573 | 220003908 | null | 0 | Not known (9) | 2013-07-07 | 2013-07-09 | Methotrexate intrathecal | 02 | N | 220021091 | FEC + DOCETAXEL |
| 220009574 | 220003908 | 1.62 | null | null | 2018-09-26 | 2018-09-27 | EC | N | N | 220021091 | CAPECITABINE |
| 220009575 | 220003909 | 0.62 | 78.1 | null | 2013-02-17 | 2013-06-21 | ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE + MELPHALAN | N | N | 220021197 | CAPECITABINE |
| 220009576 | 220003910 | 1.56 | 66.1 | Palliative (P) | 2017-01-30 | 2017-02-14 | Busulfan Oral | 02 | null | 220021277 | CISPLATIN + PEMETREXED |
| 220009577 | 220012092 | null | 87.2 | null | 2017-08-17 | 2017-08-20 | VINCRISTINE | 02 | Y | 220021328 | RUXOLITINIB |
| 220009578 | 220012092 | 1.81 | 120 | Curative (C) | 2016-10-22 | 2016-10-23 | FIGARO TRIAL | 02 | N | 220021328 | TRIPLE INTRATHECAL |
| 220009579 | 220003911 | 1.69 | 83.4 | Curative (C) | 2016-02-08 | 2016-04-11 | CAPECITABINE + TEMOZOLOMIDE | 02 | null | 220021452 | CYTARABINE + DAUNORUBICIN + ETOPOSIDE |
| 220009580 | 220003912 | 1.69 | 85.1 | Curative (C) | null | 2014-12-01 | Carboplatin + Docetaxel | N | N | 220021486 | BOSUTINIB |
| 220009581 | 220003913 | 1.69 | null | null | 2017-11-24 | 2017-11-24 | Fludarabine + Melphalan RIC Allo | N | null | 220021563 | ROMAZA TRIAL |
| 220009582 | 220012093 | 1.58 | 0 | Not known (9) | 2015-04-27 | 2015-05-07 | ATG + Busulfan + Fludarabine | 02 | N | 220021593 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 220009583 | 220012093 | 0 | 74.2 | Curative (C) | 2015-11-26 | 2015-11-26 | CARBOPLATIN + RT | N | N | 220021593 | BEP |
| 220009584 | 220003914 | 1.85 | 90 | Curative (C) | 2017-04-14 | 2017-04-14 | IDARUBICIN + MITOXANTRONE + Tretinoin | 2 | N | 220021657 | UKALL2011 |
| 220009585 | 220012094 | 1.86 | 75 | Curative (C) | null | 2014-04-12 | ALL UKALL2011 TRIAL | N | N | 220021712 | CLOFARABINE + CYTARABINE |
| 220009586 | 220012094 | null | 87.3 | Palliative (P) | 2014-02-17 | 2014-02-18 | Cyclophosphamide TBI Allograft | 02 | N | 220021712 | LI-1 TRIAL |
| 220009587 | 220019091 | 1.54 | 94.1 | Curative (C) | 2015-11-29 | 2015-12-20 | ATG + Busulfan + Fludarabine | N | N | 220021845 | CHOP R |
| 220009588 | 220003915 | null | null | null | 2017-03-02 | 2017-03-02 | Cyclophosphamide + Etoposide (PO) | null | null | 220021848 | TRASTUZUMAB |
| 220009589 | 220003916 | 1.68 | 102.4 | Curative (C) | 2017-10-03 | 2017-10-17 | Dacarbazine | 02 | N | 220021870 | FIGARO TRIAL |
| 220009590 | 220003916 | 1.89 | 70.7 | null | 2019-03-02 | 2019-03-25 | Methotrexate Intrathecal (any age) | N | N | 220021870 | CYTARABINE INTRATHECAL |
| 220009591 | 220003917 | 1.77 | null | Curative (C) | null | 2017-05-05 | CHOP R - 21 days | null | null | 220021916 | FLUDARABINE + MELPHALAN |
| 220009592 | 220003918 | null | -1 | Disease modification (D) | 2018-12-11 | 2018-12-17 | Capecitabine | N | N | 220022111 | LENALIDOMIDE |
| 220009593 | 220003918 | 1.62 | 16.8 | null | 2016-11-28 | 2016-12-15 | CHLORAMBUCIL + OBINUTUZUMAB | N | N | 220022111 | METHOTREXATE INTRATHECAL |
| 220009594 | 220003918 | 1.71 | 64.9 | null | 2014-03-09 | 2014-04-07 | Mercaptopurine | 2 | N | 220022111 | LANREOTIDE |
| 220009595 | 220003919 | null | 76.15 | Curative (C) | 2017-08-19 | 2017-08-28 | CABOZANTINIB | 2 | N | 220022434 | CLOFARABINE + CYTARABINE |
| 220009596 | 220003919 | 0 | 65 | Disease modification (D) | 2017-12-01 | 2017-12-01 | CVP R | 02 | N | 220022434 | MELPHALAN |
| 220009597 | 220003920 | null | 84.4 | null | 2019-03-10 | 2019-03-21 | CYTARABINE + Hydrocortisone + Hydrocortisone + METHOTREXATE | Y | null | 220022614 | ANAGRELIDE |
| 220009598 | 220003921 | 1.58 | 40.9 | Not known (9) | 2015-09-16 | 2015-09-23 | BUSULFAN | N | N | 220022648 | OCTREOTIDE |
| 220009599 | 220003922 | 1.95 | null | Curative (C) | 2018-06-14 | 2018-06-15 | Ipilimumab | N | N | 220022721 | CISPLATIN |
| 220009600 | 220003923 | null | 81.4 | null | 2017-05-19 | 2017-05-27 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 220022723 | FLUOROURACIL |
| 220009601 | 220003924 | 1.73 | 85.1 | Curative (C) | null | 2017-11-12 | ALL UKALL60+ TRIAL | null | null | 220022769 | CYCLOPHOSPHAMIDE |
| 220009602 | 220003925 | 1.48 | 74.8 | null | 2014-09-13 | 2014-09-16 | RUXOLITINIB | null | N | 220022881 | CISPLATIN |